Guest Commentary: Rise and Rise Again…
Here, Amrita Krishnan, MD, Nina Shah, MD, and Saad Usmani, MD, reflect on the significance of the swearing in of Kamala Harris, the daughter...
The Future of Chronic Graft-Versus-Host Disease
An Update From the 3rd NIH Chronic GVHD Consensus Conference
In this edition, Steven Pavletic, MD, and Kirk Schultz, MD, report on the progress and...
A Relevant Retirement
The Department of Medicine at Weill Cornell in New York recently held a 90th birthday celebration for Richard T. Silver, MD, which included Medical...
In Oral Maintenance Therapy in AML, Do All Roads Lead to the Epigenome?
Maintenance therapy to reduce relapse of acute myeloid leukemia (AML) and prolong overall survival (OS) has been explored since the 1960s.1 Chemotherapeutic and immunologic...
The Subspecialist Will Televisit You Now
Prior to the COVID-19 pandemic, health-care providers, payers, and patients had all gradually warmed up to the opportunities for telemedicine afforded by high-speed internet...
The Costs of Pursuing Cancer Cures
In this edition, Jori May, MD, reviews The First Cell: And the Human Costs of Pursuing Cancer to the Last, in which hematologist-oncologist Azra...
COVID-19, Cancer, and the Need for Clarity
By Aakash Desai, MD, MPH; Gilberto Lopes Jr., MD, MBA; Nicole M. Kuderer, MD; Brian I. Rini, MD; Gary H. Lyman, MD, MPH, FRCP;...
Leukemia’s Collision With Souls and Soulcraft
In this edition, Jason Gotlib, MD, MS, reviews When Blood Breaks Down: Life Lessons from Leukemia by Mikkael Sekeres, MD, MS, which explores how...
Physician, Heal Thyself: A Memoir of Castleman Disease
In this edition, John Camoriano, MD, reviews Chasing My Cure: A Doctor’s Race to Turn Hope into Action, by David Fajgenbaum, MD, MBA.
Have you...
Off to the Races: The Breakthroughs of Immunotherapy
ASH Clinical News Associate Editor David Steensma, MD, reviews The Breakthrough, which traces the evolution of immunotherapy to treat – and potentially cure – cancer.
Have you read any...